Abstract
Among the large number of nematode parasites for which humans are the definitive host, lymphatic filariae are among those with the greatest medical and public health significance. In contrast to geohelminths such as Ascaris and Trichuris species that primarily affect children, Wuchereria bancrofti, Brugia malayi, and Brugia pahangi have their most obvious clinical impact during adulthood. Accordingly, lymphatic filariasis significantly decreases the socioeconomic status of affected communities. This is reflected in objective measures such as Disability Adjusted Life Years (DALY) (Coreil et al., 1998; Haddix et al., 2000)
This introductory chapter will describe the salient biologic and epidemiological features of human lymphatic-dwelling filariae that have enabled them to be highly successful in maintaining the complex ecologic niche that involves interaction between the definitive vertebrate host and the obligatory mosquito vector. Issues of particular relevance to control strategies and future directions for research will be highlighted. More detailed discussion of protective immunity, the immunology and pathogenesis of disease, prospects for eradication, and filarial biology are presented in other chapters.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Haddix, A. C., and A, Kestler. 2000. Lymphatic filariasis: economic aspects of the disease and programmes for its elimination. Transactions of the Royal Society of Tropical Medicine and Hygiene 94:592–3.
Coreil, J., G. Mayard, J. Louis-Charles, and D. Addiss 1998. Filarial elephantiasis among Haitian women: social context and behavioural factors in treatment. Trop Med Int Health 3:467–73.
Severson, D.W., D. Zaitlin, and V.A. Kassner. 1999. Targeted identification of markers linked to malaria and filaroid nematode parasite resistance genes in the mosquito Aedes aegytpii. oGenet Res 73:217–24.
Maizels, R. M., N. Gomez-Escobar, W. F. Gregory, J. Murray, and X. Zang. 2001. Immune evasion genes from filarial nematodes. International Journal of Parasitology 31:889–98.
Selkirk, M. E., W. F. Gregory, R. E. Jenkins, and R. M. Maizels. 1993. Localization, turnover, and conservation of gp 15/400 in different stages of Brugia malayi. Parasitology 107:449–57.
Kazura, J. W., M. Bockarie, N. Alexander, R. Perry, F. Bockarie, H. Dagoro, Z. Dimber, P. Hyun, and M. P. Alpers. 1997. Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. Journal of Infectious Diseases 176:242–6.
Tisch, D., F. E. Hazlett, M. P. Alpers, W. Kastens, M. Bockarie, and J. W. Kazura. Epidemiologic and ecologic determinants of filarial antigenemia in a Wuchereria bancrofti endemic area of Papua New Guinea. Journal of Infectious Diseases (in press).
Norman, R. A., M. S. Chan, A. Srividya, S. P. Pani, K. D. Ramaiah, P. Vanamil, E. Michael, P. K. Das, and D. A. Bundy. 2000. EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect 124:529–41.
Ottesen, E. A., and T. B. Nutman. 1992. Tropical pulmonary eosinophilia. Ann Rev Med 43:417–24.
Dreyer, G., J. Noroes, J. Figueredo-Silva, and W. F. Piessens. 2000. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitology Today 16:544–8.
Malhotra, I., P. Mungai, A. Wamachi, J. Kioko, J. H. Ouma, J. W. Kazura, and C. L. King. 1999. Helminth-and Bacillus Calmette Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. Journal of Immunology 162:6843–8.
Gopinath, R., M. Ostrowski, Justement, A. S. Fauci, and T. B. Nutman. 2000. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. Journal of Infectious Diseases 182:1804–8.
Alexander, N. D., R. T. Perry, Z. B. Dimber, P. J. Hyun, M. P. Alpers, and J. W. Kazura. 1999. Acute disease episodes in a Wuchereria bancrofti endemic area of Papua New Guinea. American Journal of Tropical Medicine and Hygiene 61:319–24.
King, C. L., M. Connelly, M. P. Alpers, M. Bockarie, and J. W. Kazura. 2001. Transmission intensity determines lymphocyte responsiveness and cytokine bias in human lymphatic filariasis. Journal of Immunology 166:7427–36.
Michael, E., D. A. Bundy, and B. T. Grenfell. 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112:409–28.
Xu, B., Z. Cui, Y. Zhang, J. Chang, Q. Zhao, Q. Huang, and X. Lin. 1997. Studies on the transmission potential of filariasis in controlled areas of Henan Province. China Med Journal 110:807–10.
de Almeida, A. B., M. C. Maia e Silva, M. A. Maciel, and D. O. Freedman. 1996. The presence or absence of active infecdion, not clinical status, is most closely associated with cytokine responses in lymphatic filariasis. Journal of Infectious Diseases 173:1453–9.
Dean, M. 2000. At last, the fight against lymphatic filariasis begins. Lancet 355:385.
Horton, J., C. Witt, E. A. Ottesen and 19 coauthors. 2000. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121 (supplement): 147–60.
Dreyer, G., D. Addiss, A. Santos, J. Figueredo-Silva, and J. Noroes. 1998. Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti. Transactions of the Royal Society of Tropical Medicine and Hygiene 92:219–22.
Freedman, D.O., D. A. Plier, A. B. de Almeida, A. L. de Oliveira, J. Miranda, and C. Braga. 2001. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Med International Health 6:37–41.
Meyrowitsch, D. W., P. E. Simonsen, and W. H. Makunde. 1996. Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 90:423–8.
Bockarie, M. J., N. D. Alexander, P. Hyun, Z. Dimber, F. Bockarie, E. Ibam, M. P. Alpers, and J. W. Kazura. 1998. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti in human beings and mosquitoes. Lancet 351:1662–8.
Taylor, M. J. 2000. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control. Transactions of the Royal Society of Tropical Medicine and Hygiene 94:596–8.
Hoerauf, A., S. Mand, O. Adjei, B. Fleischer, and D. W. Buttner. 2001. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357:1415–6.
Chanteau, S., J. P. Moulia-Pelat, P. Glaziou, N. L. Nguyen, P. Luquiaud, P. Plichart, C. Plichart, P. M. Martin, and J. L. Cartel. 1994. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. Journal of Infectious Diseases 170:247–50.
Weil, G. J., R. M. Ramzy, R, Chandrashekar, A. M. Gad, R. C. Lowrie Jr, and R. Faris. 1996. Parasite antigenemia without microfilaremia in bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 55:333–337.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kazura, J.W. (2002). Lymphatic Filarial Infections: An Introduction to the Filariae. In: The Filaria. World Class Parasites, vol 5. Springer, Boston, MA. https://doi.org/10.1007/0-306-47661-4_1
Download citation
DOI: https://doi.org/10.1007/0-306-47661-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7038-9
Online ISBN: 978-0-306-47661-7
eBook Packages: Springer Book Archive